Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of four serum miRNAs as potential markers to screen for thirteen cancer types. | PLoS One | 2022 | 35687572 | PubTator, text mining | PubMed |
| An Update to Hallmarks of Cancer. | Cureus | 2022 | 35686268 | PubTator, text mining | PubMed |
| miR-106b as an emerging therapeutic target in cancer. | Genes Dis | 2022 | 35685464 | PubTator, text mining | PubMed |
| Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. | Molecules | 2022 | 35684434 | PubTator, text mining | PubMed |
| Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics. | Int J Mol Sci | 2022 | 35682560 | PubTator, text mining | PubMed |
| An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1). | Cancers (Basel) | 2022 | 35681641 | PubTator, text mining | PubMed |
| Bottom-Up Approach to the Discovery of Clinically Relevant Biomarker Genes: The Case of Colorectal Cancer. | Cancers (Basel) | 2022 | 35681633 | PubTator, text mining | PubMed |
| Cellular Senescence in Aging Lungs and Diseases. | Cells | 2022 | 35681476 | PubTator, text mining | PubMed |
| Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms. | Cells | 2022 | 35681424 | PubTator, text mining | PubMed |
| Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. | BMC Cancer | 2022 | 35676619 | PubTator, text mining | PubMed |
| IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression. | Cell Death Discov | 2022 | 35676262 | PubTator, text mining | PubMed |
| Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected. | Biomark Res | 2022 | 35672804 | PubTator, text mining | PubMed |
| P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia. | Nat Cancer | 2022 | 35668193 | PubTator, text mining | PubMed |
| The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review. | Front Oncol | 2022 | 35664800 | PubTator, text mining | PubMed |
| The Biological and Molecular Function of LINC00665 in Human Cancers. | Front Oncol | 2022 | 35664776 | PubTator, text mining | PubMed |
| MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer. | Biomark Res | 2022 | 35659780 | PubTator, text mining | PubMed |
| Network architecture of non-coding RNAs provides insights into the pathogenesis of upper tract urothelial carcinoma. | Urol Oncol | 2022 | 35659483 | PubTator, text mining | PubMed |
| Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes. | Genome Med | 2022 | 35655252 | PubTator, text mining | PubMed |
| Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial. | Sci Rep | 2022 | 35654932 | PubTator, text mining | PubMed |
| E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not-amplified neuroblastoma: Results of in silico analysis of 786 samples. | Pediatr Blood Cancer | 2022 | 35652628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=33